Clinical Roundup Moderna, Merck initiate phase III trial evaluating V940 + Keytruda in melanoma indication July 28, 2023Vol.49 No.30
Clinical Roundup MD Anderson study: Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance July 28, 2023Vol.49 No.30
Clinical Roundup Phase III KEYNOTE-A18 trial meets primary endpoint of PFS in cervical cancer July 21, 2023Vol.49 No.29
Clinical Roundup Brigham researchers reverse chemotherapy-related fertility loss using cell-based therapy July 21, 2023Vol.49 No.29
Clinical Roundup Combination therapy for pancreatic cancers appears promising in platform trial July 21, 2023Vol.49 No.29
Clinical Roundup Phase I study shows positive clinical data from dose escalation of CAR T therapy in R/R B-NHL July 21, 2023Vol.49 No.29
Clinical Roundup Some cases of Lynch syndrome are missed in younger patients under current screening guidelines July 14, 2023Vol.49 No.28
Clinical Roundup Sylvester researchers target treatment-resistant prostate cancer with oral chemo in preclinical study July 14, 2023Vol.49 No.28
